Login

Mr. David Sin is the Co-Founder, Group President, and Deputy Chairman of the Board of Fullerton Health, and an alumnus of The Chinese High School. 00:10:00

Share On Facebook Share On Twitter

Chang Ching Wu CEO. Chief Executive Officer

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Pioneering medical technology company operating at the forefront of predictive diagnostics and bioanalytical services|Dr Richard Lipscombe,MD,Proteomics International Laboratories Ltd
00:10:00
MINTO Apartment REIT Rings Opening Bell at Toronto Stock Exchange
00:10:00
An interview featuring Jesse Koenig and Ryan Saul, co-founder and vice-president of Tempo Automation, USA, discussing topics related to Europlacer, available on YouTube Kids.
00:10:00
Powering the Future of AI: Deep Learning Meets High-Performance Computing with Yann LeCun and Bill Dally|Yann LeCun, Chief AI Scientist,Meta
00:10:00
Update on Copper Drilling Program and Financing at Cerro Blanco
00:10:00
Key Traits for a Successful Founding Team: Vision, Resilience, and Leadership
00:10:00
Breaking Boundaries: ESI's Vision for a Predictive, Real-Time, and Immersive Digital Transformation in Industry | Francis Griffiths, EXECUTIVE VICE-PRESIDENT, CHIEF REVENUE OFFICER of ESI Group SA
00:10:00
"A Fireside Chat on Leadership and Global Insights: David McCormick Interviews Bridgewater's Karen Karniol-Tambour"
00:10:00
West Haven Gold Corp. CEO Gareth Thomas Highlights High-Grade Gold-Silver Intercepts in BC
00:10:00
Aton Resources CEO Tonno Vahk Outlines Strategic Goals and Market Challenges in Exclusive Town Hall Discussion|Tonno Vahk,CEO,Aton Resources Inc
00:10:00
Golden Rim Resources: Advancing Gold in Burkina Faso and Selling Chilean Assets
00:10:00
PIC CEO Abel Reflects on Asset Growth, Market Recovery, and Social Impact Amidst Pandemic Turbulence | Abel Sithole, CEO , Public Investment Corporation.

© 2017 - Neuhu+